Maganin Sinovac na kasar Sin da kuma rigakafin Covichield na Indiya za a "gane" a cikin sanarwar hukuma ta Ostiraliya don buɗe kan iyaka.

Hukumar Kula da Magunguna ta Australiya (TGA) ta ba da sanarwar amincewa da Coxing Vaccines a China da Covichield Covid-19 Vaccines a Indiya, wanda ke ba da hanya ga masu yawon bude ido da ɗaliban ƙasashen waje da aka yi wa allurar rigakafin nan biyu don shiga Australia.Firayim Ministan Australiya Scott Morrison ya fada a wannan rana cewa TGA ta fitar da bayanan tantancewar farko na rigakafin Coxing Coronavac na kasar Sin da kuma allurar rigakafin Covishield na Indiya (ainihin rigakafin AstraZeneca da aka samar a Indiya), kuma ya ba da shawarar cewa ya kamata a jera wadannan alluran rigakafin guda biyu a matsayin "gane."Alurar riga kafi".Yayin da adadin allurar rigakafin cutar ta Ostiraliya ke gabatowa muhimmin matakin kashi 80%, kasar ta fara daukar wasu tsauraran takunkumin kan iyaka a duniya kan annobar, kuma tana shirin bude iyakokinta na kasa da kasa a watan Nuwamba.Baya ga sabbin alluran rigakafin guda biyu da aka amince da su, allurar rigakafin da TGA ta amince da su a halin yanzu sun haɗa da alurar rigakafin Pfizer/BioNTech (Comirnaty), rigakafin AstraZeneca (Vaxzevria), rigakafin Modena (Spikevax) da rigakafin Johnson & Johnson na Janssen.

labarai

Duk da haka, yana da mahimmanci a lura cewa an jera shi a matsayin "alurar rigakafin da aka yarda" ba yana nufin cewa an yarda da shi don maganin alurar riga kafi a Ostiraliya, kuma an tsara su biyu daban. TGA ba ta amince da ko dai maganin alurar riga kafi don amfani a Ostiraliya ba, kodayake Alurar riga kafi. Hukumar Lafiya ta Duniya ta ba da takaddun shaida don amfani da gaggawa.

Wannan ya yi kama da wasu ƙasashe a Turai da Amurka. A ƙarshen Satumba, Amurka ta ba da sanarwar cewa duk mutanen da suka karɓi allurar rigakafin da Hukumar Lafiya ta Duniya ta tabbatar don amfani da gaggawa za a ɗauke su da “cikakken allurar rigakafi” kuma a ba su izinin shiga ƙasar. Wannan yana nufin cewa fasinjojin kasashen waje da aka yi wa alurar riga kafi da Sinovac, Sinopharm da sauran alurar riga kafi na kasar Sin wadanda aka sanya su cikin jerin ayyukan gaggawa na WHO za su iya shiga Amurka bayan nuna shaidar "cikakken allurar rigakafi" da rahoton rashin lafiyar nucleic a cikin kwanaki 3 kafin shiga cikin jirgin. jirgin sama.

Bugu da kari, TGA ta tantance alluran rigakafin guda shida, amma har yanzu ba a “gane wasu hudu ba” saboda karancin bayanai, a cewar sanarwar.

Su ne: Bibp-corv, wanda kamfanin Sinopharmacy na kasar Sin ya kirkiro;Convidecia, wanda kamfanin Convidecia na kasar Sin ya yi;Covaxin, wanda Bharat Biotech na Indiya ya yi;da Gamaleya na RashaSputnik V, wanda Cibiyar ta haɓaka.

Ko ta yaya, shawarar Jumma'a na iya buɗe kofa ga dubunnan ɗaliban ƙasashen waje waɗanda aka juya daga Ostiraliya yayin bala'in. Ilimin ƙasa da ƙasa tushen samun kudin shiga ne ga Ostiraliya, yana samun dala biliyan 14.6 (dala biliyan 11) a cikin 2019 a New South Wales. kadai.

Fiye da dalibai 57,000 an kiyasta su kasance a kasashen waje, bisa ga gwamnatin NSW. 'Yan kasar Sin su ne mafi girma tushen dalibai na duniya a Australia, sannan Indiya, Nepal da Vietnam, bisa ga bayanan sashen kasuwanci.


Lokacin aikawa: Nuwamba 18-2021